Insider Trading History of Skolnick Phil


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Skolnick Phil since year 2005. The trader's CIK number is 1358116. At the time of the last reporting, Skolnick Phil was the Chief Scientific Officer of Opiant Pharmaceuticals, Inc. . (stock ticker symbol OPNT). See this page for all insider trading activities at Opiant Pharmaceuticals, Inc. .

Note that in the past Skolnick Phil also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Skolnick Phil since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-11-04 OPNT Opiant Pharmaceuticals, Inc. Sale 299 15.28 4,568
2019-11-05 OPNT Opiant Pharmaceuticals, Inc. Sale 2,500 14.89 37,225
2019-11-01 OPNT Opiant Pharmaceuticals, Inc. Option Ex 10,000 9.00 90,000
2019-11-01 OPNT Opiant Pharmaceuticals, Inc. Sale 7,201 15.10 108,735
2019-10-02 OPNT Opiant Pharmaceuticals, Inc. Sale 1,102 14.57 16,056
2019-10-01 OPNT Opiant Pharmaceuticals, Inc. Option Ex 10,000 9.00 90,000
2019-10-01 OPNT Opiant Pharmaceuticals, Inc. Sale 7,289 14.79 107,804
2019-10-03 OPNT Opiant Pharmaceuticals, Inc. Sale 1,609 14.27 22,960
2019-09-03 OPNT Opiant Pharmaceuticals, Inc. Option Ex 10,000 9.00 90,000
2019-09-04 OPNT Opiant Pharmaceuticals, Inc. Sale 2,494 14.37 35,838
2019-09-03 OPNT Opiant Pharmaceuticals, Inc. Sale 7,506 14.08 105,684
2019-08-02 OPNT Opiant Pharmaceuticals, Inc. Sale 1,558 11.30 17,605
2019-08-01 OPNT Opiant Pharmaceuticals, Inc. Sale 8,442 11.66 98,433
2019-08-01 OPNT Opiant Pharmaceuticals, Inc. Option Ex 10,000 9.00 90,000
2019-07-01 OPNT Opiant Pharmaceuticals, Inc. Option Ex 10,000 9.00 90,000
2019-07-01 OPNT Opiant Pharmaceuticals, Inc. Sale 7,805 13.20 103,026
2019-07-02 OPNT Opiant Pharmaceuticals, Inc. Sale 2,195 13.16 28,886
2019-06-03 OPNT Opiant Pharmaceuticals, Inc. Option Ex 10,000 9.00 90,000
2019-06-03 OPNT Opiant Pharmaceuticals, Inc. Sale 8,414 11.72 98,612
2019-06-04 OPNT Opiant Pharmaceuticals, Inc. Sale 1,586 11.63 18,445
2019-05-01 OPNT Opiant Pharmaceuticals, Inc. Option Ex 10,000 9.00 90,000
2019-05-01 OPNT Opiant Pharmaceuticals, Inc. Sale 8,559 11.41 97,658
2019-05-02 OPNT Opiant Pharmaceuticals, Inc. Sale 1,441 11.24 16,196
2019-04-01 OPNT Opiant Pharmaceuticals, Inc. Option Ex 10,000 9.00 90,000
2019-04-01 OPNT Opiant Pharmaceuticals, Inc. Sale 7,993 12.71 101,591
2019-04-02 OPNT Opiant Pharmaceuticals, Inc. Sale 2,007 12.47 25,027
2019-03-01 OPNT Opiant Pharmaceuticals, Inc. Sale 10,000 14.96 149,650
2019-03-01 OPNT Opiant Pharmaceuticals, Inc. Option Ex 10,000 9.00 90,000
2019-02-01 OPNT Opiant Pharmaceuticals, Inc. Sale 7,441 15.32 113,996
2019-02-01 OPNT Opiant Pharmaceuticals, Inc. Option Ex 10,000 9.00 90,000
2019-02-04 OPNT Opiant Pharmaceuticals, Inc. Sale 2,559 15.31 39,178
2019-01-02 OPNT Opiant Pharmaceuticals, Inc. Option Ex 10,000 9.00 90,000
2019-01-02 OPNT Opiant Pharmaceuticals, Inc. Sale 7,768 13.84 107,509
2019-01-04 OPNT Opiant Pharmaceuticals, Inc. Sale 2,232 13.48 30,087
2018-12-06 OPNT Opiant Pharmaceuticals, Inc. Sale 3,015 16.15 48,692
2018-12-03 OPNT Opiant Pharmaceuticals, Inc. Sale 1,306 15.85 20,700
2018-12-03 OPNT Opiant Pharmaceuticals, Inc. Option Ex 4,321 9.00 38,889
2018-11-06 OPNT Opiant Pharmaceuticals, Inc. Sale 3,217 16.81 54,077
2018-11-05 OPNT Opiant Pharmaceuticals, Inc. Sale 300 17.33 5,198
2018-11-01 OPNT Opiant Pharmaceuticals, Inc. Sale 1,521 18.14 27,590
2018-11-01 OPNT Opiant Pharmaceuticals, Inc. Option Ex 5,038 9.00 45,342
2018-10-02 OPNT Opiant Pharmaceuticals, Inc. Sale 1,433 17.24 24,704
2018-10-03 OPNT Opiant Pharmaceuticals, Inc. Sale 1,500 19.23 28,837
2018-10-04 OPNT Opiant Pharmaceuticals, Inc. Sale 1,845 18.43 34,003
2018-10-02 OPNT Opiant Pharmaceuticals, Inc. Option Ex 4,778 9.00 43,002
2006-04-03 DOVP Dov Pharmaceutical Inc Sale 5,000 16.05 80,260

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Skolnick Phil (Chief Scientific Officer of Opiant Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month